Home > Compound List > Compound details
162359-56-0 molecular structure
click picture or here to close

2-amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol hydrochloride

ChemBase ID: 73073
Molecular Formular: C19H34ClNO2
Molecular Mass: 343.93176
Monoisotopic Mass: 343.22780701
SMILES and InChIs

SMILES:
c1(ccc(cc1)CCCCCCCC)CCC(CO)(N)CO.Cl
Canonical SMILES:
CCCCCCCCc1ccc(cc1)CCC(CO)(CO)N.Cl
InChI:
InChI=1S/C19H33NO2.ClH/c1-2-3-4-5-6-7-8-17-9-11-18(12-10-17)13-14-19(20,15-21)16-22;/h9-12,21-22H,2-8,13-16,20H2,1H3;1H
InChIKey:
SWZTYAVBMYWFGS-UHFFFAOYSA-N

Cite this record

CBID:73073 http://www.chembase.cn/molecule-73073.html

Collapse All Expand All

NAMES AND DATABASE IDS

NAMES AND DATABASE IDS

Names Database IDs
IUPAC name
2-amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol hydrochloride
IUPAC Traditional name
fingolimod hydrochloride
Synonyms
Fingolimod
Gilenia
FTY720
2-Amino-2-(2-(4-octylphenyl)ethyl)propane-1,3-diol Hydrochloride
Fingolimod Hydrochloride
FTY720 Hydrochloride
2-Amino-2-(4-octylphenethyl)propane-1,3-diol hydrochloride
CAS Number
162359-56-0
MDL Number
MFCD14705150
PubChem SID
162037993
PubChem CID
107969

DATA SOURCES

DATA SOURCES

All Sources Commercial Sources Non-commercial Sources
Data Source Data ID
PubChem 107969 external link

CALCULATED PROPERTIES

CALCULATED PROPERTIES

JChem
Acid pKa 14.411364  H Acceptors
H Donor LogD (pH = 5.5) 1.0859709 
LogD (pH = 7.4) 2.1161747  Log P 4.060978 
Molar Refractivity 93.28 cm3 Polarizability 36.89879 Å3
Polar Surface Area 66.48 Å2 Rotatable Bonds 12 
Lipinski's Rule of Five true 

PROPERTIES

PROPERTIES

Physical Property Safety Information Pharmacology Properties Product Information Bioassay(PubChem)
Solubility
DMSO expand Show data source
Ethanol expand Show data source
Methanol expand Show data source
Apperance
White Solid expand Show data source
Melting Point
102-107°C expand Show data source
Storage Condition
-20°C expand Show data source
-20°C Freezer expand Show data source
MSDS Link
Download expand Show data source
Target
Bcr-Abl expand Show data source
S1P receptor expand Show data source
Purity
95+% expand Show data source
Salt Data
Hydrochloride expand Show data source
Certificate of Analysis
Download expand Show data source

DETAILS

DETAILS

Selleck Chemicals Selleck Chemicals TRC TRC
Selleck Chemicals - S5002 external link
Research Area
Description Immunology
Biological Activity
Description FTY720 (Fingolimod, Gilenya) is a S1P antagonist with IC50 of 0.033 nM.
Targets S1P receptor
IC50 0.033 nM [1]
In Vitro The inhibitory effect of S1P is revered by various concentrations of FTY720, with IC50 effect of 173 nM. In addition, FTY720 (10 nM) alone exerts no effect on the expression of co-stimulatory molecules. FTY720 reverses the increased expression of HLA-I induced by S1P for both the percentages of cells and the MFI, upon comparing the effect of S1P to the effect of combining S1P with FTY720. [1] Medium and high-dose FTY720-P also enhances the levels of TGF-β1. TGF-β1 and Foxp3 mRNA expression are upregulated in the high-dose FTY720-P group. The proliferation of effector T cells is suppressed significantly in the medium and high-dose FTY720-P group at a Treg/Teff cell ratio of 1:1. At a ratio of 1:1, the proliferation of effector T cells is also suppressed in the high-dose FTY720 group. [2]
In Vivo FTY720 is effective in Ph+ but not Ph- ALL xenografts using an early disease model. FTY720 produces a significant reduction in disease burden in the Ph+ ALL xenografts using an early disease model. Ph+ human ALL xenografts responds to FTY720 with an 80±12% reduction in overall disease if treatment has been initiated early on. In contrast, treatment of mice with FTY720 does not result in reduced leukemia compared to controls using four separate human Ph- ALL xenografts. [3]
Clinical Trials FTY720 has enterd in a phase IV clinical trial in the treatment of multiple sclerosis anbd relapsing-remitting.
Features
Combination Therapy
Description Cyclosporine A (CsA) at doses of 0.3 mg/kg/day and 1 mg/kg/day has small effect on graft survival. Even at the lower CsA dose, adding 0.03 mg/kg FTY720 prolongs the MST from 7 days to 22 days. The next higher doses, 0.1 mg/kg/day and 0.3 mg/kg/day FTY720 prolongs MST to 32.5 days and 41 days, respectively. [4] FTY720 plus Avonex, Copaxone, Rebif, Betaseron or Extavia has entered in a phase IV clinical trial in the treatments of relapsing forms of multiple sclerosis.
Protocol
Cell Assay [1]
Cell Lines Immature DCs
Concentrations 10 nM
Incubation Time 4 hours
Methods Immature DCs are left intact or are incubated with 2 μM S1P, 10 nM FTY720, 10 nM SEW2871 or the combinations of S1P with these drugs for 4 hours. As a control 1 μg/mL LPS is used. The cells are washed and incubated in a 96-well plate (v-bottom, 2 × 105 cells per well), washed again and resuspended in PBS buffer containing 0.1% sodium azide. They are labeled with 1 μg/mL FITC-conjugated mouse anti-human CD80, 1 μg/mL FITC-conjugated mouse anti-human CD83, 1 μg/mL FITC-conjugated mouse anti-human CD86, 1 μg/mL FITC-conjugated mouse anti-human HLA-class I, 1 μg/mL FITC-conjugated mouse anti-human HLA-DR, 1 μg/mL FITC-conjugated mouse anti-human HLA-E, or 1 μg/mL FITC-conjugated mouse IgG as a control. The cells are washed twice, and examined in the flow cytometer. Markers are set according to the isotype control FITC-conjugated mouse IgG. To stain NK cells with antibodies for various NK cell activating receptors, they are either left untreated or incubated with 2 μM S1P for 4 hours, washed and stained with 1 μg/mL PE-conjugated mouse anti-human NKp30 (CD337), 1 μg/mL PE-conjugated mouse anti-human NKp44 (CD336), 1 μg/mL PE-conjugated mouse anti-human NKG2D (CD314), or as a control 1 μg/mL PE-conjugated mouse IgG1, for 45 min at 4 °C. NK cells are also stained with 1 μg/mL FITC-conjugated anti-killer inhibitory receptor (KIR)/CD158 antibody which recognizes KIR2DL2, KIR2DL3, KIR2DS2 and KIR2DS4, and as a control with FITC-conjugated mouse IgG. The cells are washed twice, and examined in the flow cytometer. Markers are set according to the isotype control PE-conjugated or FITC-conjugated mouse IgG.
Animal Study [3]
Animal Models NOD/SCIDγc?/? mice bearing ALL cells.
Formulation 2% ethanol or saline
Doses 5 mg/kg/day, 10 mg/kg/day
Administration Administered via i.p.
References
[1] Rolin J, et al. Cancer Immunol Immunother. 2010, 59(4), 575-586.
[2] Liu Y, et al. Int J Mol Med. 2012, 30(1), 211-219.
[3] Wallington-Beddoe CT, et al. PLoS One. 2012, 7(5), e36429.
[4] Nikolova Z, et al. Transpl Immunol. 2001, 8(4), 267-277.
Toronto Research Chemicals - F805000 external link
FTY720 is a derivative of ISP-1 (myriocin), a fungal metabolite of the Chinese herb Iscaria sinclarii as well as a structural analogue of Sphingosine. FTY720 is a novel immune modulator that prolongs allograft transplant survival in numberour models by

REFERENCES

REFERENCES

From Suppliers Google Scholar IconGoogle Scholar PubMed iconPubMed Google Books IconGoogle Books
  • Searching...Please wait...

PATENTS

PATENTS

PubChem iconPubChem Patent Google Patent Search IconGoogle Patent

INTERNET

INTERNET

Baidu iconBaidu google iconGoogle